Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Click Me!

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 29 September 2006:
Vol. 313. no. 5795, pp. 1960 - 1964
DOI: 10.1126/science.1129139
Prev | Table of Contents | Next

Reports

Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

Jérôme Galon,1*{dagger} Anne Costes,1 Fatima Sanchez-Cabo,2 Amos Kirilovsky,1 Bernhard Mlecnik,2 Christine Lagorce-Pagès,3 Marie Tosolini,1 Matthieu Camus,1 Anne Berger,4 Philippe Wind,4 Franck Zinzindohoué,5 Patrick Bruneval,6 Paul-Henri Cugnenc,5 Zlatko Trajanoski,2 Wolf-Herman Fridman,1,7 Franck Pagès1,7{dagger}

The role of the adaptive immune response in controlling the growth and recurrence of human tumors has been controversial. We characterized the tumor-infiltrating immune cells in large cohorts of human colorectal cancers by gene expression profiling and in situ immunohistochemical staining. Collectively, the immunological data (the type, density, and location of immune cells within the tumor samples) were found to be a better predictor of patient survival than the histopathological methods currently used to stage colorectal cancer. The results were validated in two additional patient populations. These data support the hypothesis that the adaptive immune response influences the behavior of human tumors. In situ analysis of tumor-infiltrating immune cells may therefore be a valuable prognostic tool in the treatment of colorectal cancer and possibly other malignancies.

1 INSERM U 255, Paris, 75006 France; Université Paris-Descartes Paris 5, Faculté de Médecine, Paris, 75006 France; and Université Pierre et Marie Curie Paris 6, Institut des Cordeliers, Paris, 75006 France.
2 Institute for Genomics and Bioinformatics, Graz University of Technology, Graz, Austria.
3 Department of Pathology, Avicenne Hospital, Bobigny, 93017 France.
4 Department of Digestive Surgery, Avicenne Hospital, Bobigny, 93017 France.
5 Department of General and Digestive Surgery, Georges Pompidou European Hospital, AP-HP, Paris, 75015 France.
6 Department of Pathology, Georges Pompidou European Hospital, AP-HP, Paris, 75015 France.
7 Department of Immunology, Georges Pompidou European Hospital, AP-HP, Paris, 75015 France.

{dagger} These authors contributed equally to this work.

* To whom correspondence should be addressed. E-mail: jerome.galon{at}u255.bhdc.jussieu.fr

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Patterns of cell signaling pathway activation that characterize mammary development.
E. R. Andrechek, S. Mori, R. E. Rempel, J. T. Chang, and J. R. Nevins (2008)
Development 135, 2403-2413
   Abstract »    Full Text »    PDF »
Cancer Immunology.
O. J. Finn (2008)
N. Engl. J. Med. 358, 2704-2715
   Full Text »    PDF »
High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma.
X.-D. Zhu, J.-B. Zhang, P.-Y. Zhuang, H.-G. Zhu, W. Zhang, Y.-Q. Xiong, W.-Z. Wu, L. Wang, Z.-Y. Tang, and H.-C. Sun (2008)
J. Clin. Oncol. 26, 2707-2716
   Abstract »    Full Text »    PDF »
Foxp3 and microsatellite stability phenotype in colorectal cancer.
C. Loddenkemper, D. Nagorsen, and M. Zeitz (2008)
Gut 57, 725-726
   Full Text »    PDF »
Crucial Role of Interleukin-4 in the Survival of Colon Cancer Stem Cells.
M. G. Francipane, M. Perez Alea, Y. Lombardo, M. Todaro, J.P. Medema, and G. Stassi (2008)
Cancer Res. 68, 4022-4025
   Abstract »    Full Text »    PDF »
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas.
S Le Gouvello, S Bastuji-Garin, N Aloulou, H Mansour, M-T Chaumette, F Berrehar, A Seikour, A Charachon, M Karoui, K Leroy, et al. (2008)
Gut 57, 772-779
   Abstract »    Full Text »    PDF »
Phenotypic Analysis of Prostate-Infiltrating Lymphocytes Reveals TH17 and Treg Skewing.
K. S. Sfanos, T. C. Bruno, C. H. Maris, L. Xu, C. J. Thoburn, A. M. DeMarzo, A. K. Meeker, W. B. Isaacs, and C. G. Drake (2008)
Clin. Cancer Res. 14, 3254-3261
   Abstract »    Full Text »    PDF »
Metinel Node--The First Lymph Node Draining a Metastasis--Contains Tumor-Reactive Lymphocytes.
K. Dahl, M. Karlsson, P. Marits, A. Hoffstedt, O. Winqvist, and M. Thorn (2008)
Ann. Surg. Oncol. 15, 1454-1463
   Abstract »    Full Text »    PDF »
Prognostic and predictive factors in colorectal cancer.
I Zlobec and A Lugli (2008)
J. Clin. Pathol. 61, 561-569
   Abstract »    Full Text »    PDF »
Interleukin-15/Interleukin-15R{alpha} Complexes Promote Destruction of Established Tumors by Reviving Tumor-Resident CD8+ T Cells.
M. Epardaud, K. G. Elpek, M. P. Rubinstein, A.-r. Yonekura, A. Bellemare-Pelletier, R. Bronson, J. A. Hamerman, A. W. Goldrath, and S. J. Turley (2008)
Cancer Res. 68, 2972-2983
   Abstract »    Full Text »    PDF »
Disrupted Expression of CXCL5 in Colorectal Cancer Is Associated with Rapid Tumor Formation in Rats and Poor Prognosis in Patients.
F. M. Speetjens, P. J.K. Kuppen, M. H. Sandel, A. G. Menon, D. Burg, C. J.H. van de Velde, R. A.E.M. Tollenaar, H. J.G.M. de Bont, and J. F. Nagelkerke (2008)
Clin. Cancer Res. 14, 2276-2284
   Abstract »    Full Text »    PDF »
Signatures Associated with Rejection or Recurrence in HER-2/neu-Positive Mammary Tumors.
A. Worschech, M. Kmieciak, K. L. Knutson, H. D. Bear, A. A. Szalay, E. Wang, F. M. Marincola, and M. H. Manjili (2008)
Cancer Res. 68, 2436-2446
   Abstract »    Full Text »    PDF »
Stress, Immunity, and Cervical Cancer: Biobehavioral Outcomes of a Randomized Clinical Trail.
E. L. Nelson, L. B. Wenzel, K. Osann, A. Dogan-Ates, N. Chantana, A. Reina-Patton, A. K. Laust, K. P. Nishimoto, A. Chicz-DeMet, N. du Pont, et al. (2008)
Clin. Cancer Res. 14, 2111-2118
   Abstract »    Full Text »    PDF »
Capitalizing on the Immunogenicity of Dying Tumor Cells.
C. Fonseca and G. Dranoff (2008)
Clin. Cancer Res. 14, 1603-1608
   Abstract »    Full Text »    PDF »
Tumor-Infiltrating Lymphocytes and Perforation in Colon Cancer Predict Positive Response to 5-Fluorouracil Chemotherapy.
M. Morris, C. Platell, and B. Iacopetta (2008)
Clin. Cancer Res. 14, 1413-1417
   Abstract »    Full Text »    PDF »
Combining the Antigen Processing Components TAP and Tapasin Elicits Enhanced Tumor-Free Survival.
Y. Lou, G. Basha, R. P. Seipp, B. Cai, S. S. Chen, A. R. Moise, A. P. Jeffries, R. S. Gopaul, T. Z. Vitalis, and W. A. Jefferies (2008)
Clin. Cancer Res. 14, 1494-1501
   Abstract »    Full Text »    PDF »
Inciting inflammation: the RAGE about tumor promotion.
M. Dougan and G. Dranoff (2008)
J. Exp. Med. 205, 267-270
   Abstract »    Full Text »    PDF »
Epithelial Human Leukocyte Antigen-DR Expression Predicts Reduced Recurrence Rates and Prolonged Survival in Rectal Cancer Patients.
E. C. de Bruin, C. J.H. van de Velde, J. H. J.M. van Krieken, C. A.M. Marijnen, and J. P. Medema (2008)
Clin. Cancer Res. 14, 1073-1079
   Abstract »    Full Text »    PDF »
A Macrophage Gene Expression Signature Defines a Field Effect in the Lung Tumor Microenvironment.
R. S. Stearman, L. Dwyer-Nield, M. C. Grady, A. M. Malkinson, and M. W. Geraci (2008)
Cancer Res. 68, 34-43
   Abstract »    Full Text »    PDF »
Molecular Classification and Correlates in Colorectal Cancer.
S. Ogino and A. Goel (2008)
J. Mol. Diagn. 10, 13-27
   Abstract »    Full Text »    PDF »
Differing Phenotypes between Intraepithelial and Stromal Lymphocytes in Early-Stage Tongue Cancer.
F. Katou, H. Ohtani, Y. Watanabe, T. Nakayama, O. Yoshie, and K. Hashimoto (2007)
Cancer Res. 67, 11195-11201
   Abstract »    Full Text »    PDF »
Anti-CD40 Conditioning Enhances the TCD8 Response to a Highly Tolerogenic Epitope and Subsequent Immunotherapy of Simian Virus 40 T Antigen-Induced Pancreatic Tumors.
P. Otahal, B. B. Knowles, S. S. Tevethia, and T. D. Schell (2007)
J. Immunol. 179, 6686-6695
   Abstract »    Full Text »    PDF »
History of Allergy and Reduced Incidence of Colorectal Cancer, Iowa Women's Health Study.
A. E. Prizment, A. R. Folsom, J. R. Cerhan, A. Flood, J. A. Ross, and K. E. Anderson (2007)
Cancer Epidemiol. Biomarkers Prev. 16, 2357-2362
   Abstract »    Full Text »    PDF »
Telomerase-Specific T-Cell Immunity in Breast Cancer: Effect of Vaccination on Tumor Immunosurveillance.
S. M. Domchek, A. Recio, R. Mick, C. E. Clark, E. L. Carpenter, K. R. Fox, A. DeMichele, L. M. Schuchter, M. S. Leibowitz, M. H. Wexler, et al. (2007)
Cancer Res. 67, 10546-10555
   Abstract »    Full Text »    PDF »
The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer.
I. Atreya, C. C Schimanski, C. Becker, S. Wirtz, H. Dornhoff, E. Schnurer, M. R Berger, P. R Galle, W. Herr, and M. F Neurath (2007)
Gut 56, 1572-1578
   Abstract »    Full Text »    PDF »
Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies.
I. G. Schuster, D. H. Busch, E. Eppinger, E. Kremmer, S. Milosevic, C. Hennard, C. Kuttler, J. W. Ellwart, B. Frankenberger, E. Nossner, et al. (2007)
Blood 110, 2931-2939
   Abstract »    Full Text »    PDF »
Dynamics of the Immune Reaction to Pancreatic Cancer from Inception to Invasion.
C. E. Clark, S. R. Hingorani, R. Mick, C. Combs, D. A. Tuveson, and R. H. Vonderheide (2007)
Cancer Res. 67, 9518-9527
   Abstract »    Full Text »    PDF »
A Mechanistic Perspective of Monoclonal Antibodies in Cancer Therapy Beyond Target-Related Effects.
S. E. Strome, E. A. Sausville, and D. Mann (2007)
Oncologist 12, 1084-1095
   Abstract »    Full Text »    PDF »
B7-H3 Ligand Expression by Prostate Cancer: A Novel Marker of Prognosis and Potential Target for Therapy.
T. J. Roth, Y. Sheinin, C. M. Lohse, S. M. Kuntz, X. Frigola, B. A. Inman, A. E. Krambeck, M. E. Mckenney, R. J. Karnes, M. L. Blute, et al. (2007)
Cancer Res. 67, 7893-7900
   Abstract »    Full Text »    PDF »
Interleukin-12: Biological Properties and Clinical Application.
M. Del Vecchio, E. Bajetta, S. Canova, M. T. Lotze, A. Wesa, G. Parmiani, and A. Anichini (2007)
Clin. Cancer Res. 13, 4677-4685
   Abstract »    Full Text »    PDF »
Impaired Th1/Tc1 Cytokine Production of Tumor-Infiltrating Lymphocytes in a Model of Primary Intraocular B-Cell Lymphoma.
V. Touitou, C. Daussy, B. Bodaghi, S. Camelo, Y. de Kozak, P. Lehoang, M.-C. Naud, A. Varin, B. Thillaye-Goldenberg, H. Merle-Beral, et al. (2007)
Invest. Ophthalmol. Vis. Sci. 48, 3223-3229
   Abstract »    Full Text »    PDF »
Interactions between epithelial cells and leukocytes in immunity and tissue homeostasis.
R. Shaykhiev and R. Bals (2007)
J. Leukoc. Biol. 82, 1-15
   Abstract »    Full Text »    PDF »
Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After Resection.
Q. Gao, S.-J. Qiu, J. Fan, J. Zhou, X.-Y. Wang, Y.-S. Xiao, Y. Xu, Y.-W. Li, and Z.-Y. Tang (2007)
J. Clin. Oncol. 25, 2586-2593
   Abstract »    Full Text »    PDF »
Prognostic Significance of Immune Subset Measurement in Individuals With AIDS-Associated Kaposi's Sarcoma.
J. Stebbing, A. Sanitt, A. Teague, T. Powles, M. Nelson, B. Gazzard, and M. Bower (2007)
J. Clin. Oncol. 25, 2230-2235
   Abstract »    Full Text »    PDF »
Loss of Functional Fas Ligand Enhances Intestinal Tumorigenesis in the Min Mouse Model.
B. Fingleton, K. J. Carter, and L. M. Matrisian (2007)
Cancer Res. 67, 4800-4806
   Abstract »    Full Text »    PDF »
T-Cell Distribution and Adhesion Receptor Expression in Metastatic Melanoma.
C. Weishaupt, K. N. Munoz, E. Buzney, T. S. Kupper, and R. C. Fuhlbrigge (2007)
Clin. Cancer Res. 13, 2549-2556
   Abstract »    Full Text »    PDF »
Association Versus Causation Versus Quality Improvement: Setting Benchmarks for Lymph Node Evaluation in Colon Cancer.
R. Ricciardi and N. N. Baxter (2007)
J Natl Cancer Inst 99, 414-415
   Full Text »    PDF »
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma.
P. Sharma, Y. Shen, S. Wen, S. Yamada, A. A. Jungbluth, S. Gnjatic, D. F. Bajorin, V. E. Reuter, H. Herr, L. J. Old, et al. (2007)
PNAS 104, 3967-3972
   Abstract »    Full Text »    PDF »
The Adaptive Immunologic Microenvironment in Colorectal Cancer: A Novel Perspective.
J. Galon, W.-H. Fridman, and F. Pages (2007)
Cancer Res. 67, 1883-1886
   Abstract »    Full Text »    PDF »
Modulation of CD103 Expression on Human Colon Carcinoma-Specific CTL.
K.-L. Ling, N. Dulphy, P. Bahl, M. Salio, K. Maskell, J. Piris, B. F. Warren, B. D. George, N. J. Mortensen, and V. Cerundolo (2007)
J. Immunol. 178, 2908-2915
   Abstract »    Full Text »    PDF »
In Reply.
N. N. Baxter (2007)
J. Clin. Oncol. 25, 463-464
   Full Text »    PDF »
Minerva.
(2006)
BMJ 333, 762
   Full Text »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)